Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $2,300 | 65 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Biogen, Inc. | $937.04 | 49 | $0 (2024) |
| EMD Serono, Inc. | $681.89 | 6 | $0 (2023) |
| TG Therapeutics, Inc. | $355.25 | 3 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $188.74 | 5 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $119.93 | 1 | $0 (2024) |
| Genentech USA, Inc. | $17.41 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $542.60 | 6 | TG Therapeutics, Inc. ($252.22) |
| 2023 | $1,086 | 27 | EMD Serono, Inc. ($681.89) |
| 2022 | $439.10 | 22 | Biogen, Inc. ($375.36) |
| 2021 | $232.10 | 10 | Biogen, Inc. ($232.10) |
All Payment Transactions
65 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 06/27/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 05/12/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $133.83 | General |
| Category: Immunology | ||||||
| 03/19/2024 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $28.04 | General |
| Category: Neurology | ||||||
| 03/14/2024 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $119.93 | General |
| Category: Oncology | ||||||
| 02/12/2024 | Genentech USA, Inc. | Ocrevus (Biological) | Food and Beverage | In-kind items and services | $17.41 | General |
| Category: Immunology | ||||||
| 01/30/2024 | TG Therapeutics, Inc. | BRIUMVI (Drug) | Food and Beverage | In-kind items and services | $118.39 | General |
| Category: Immunology | ||||||
| 12/19/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $10.11 | General |
| Category: Neurology | ||||||
| 12/07/2023 | Biogen, Inc. | TYSABRI (Biological), AVONEX, VUMERITY | Food and Beverage | In-kind items and services | $23.65 | General |
| Category: Neurology | ||||||
| 10/26/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $121.01 | General |
| 10/24/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $19.95 | General |
| Category: Neurology | ||||||
| 10/18/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $8.96 | General |
| Category: Neurology | ||||||
| 10/18/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $3.90 | General |
| Category: Neurology | ||||||
| 09/26/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: Neurology | ||||||
| 09/11/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Neurology | ||||||
| 08/16/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $1.36 | General |
| Category: Neurology | ||||||
| 08/15/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $2.46 | General |
| Category: Neurology | ||||||
| 08/03/2023 | Biogen, Inc. | AVONEX (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Neurology | ||||||
| 08/01/2023 | Biogen, Inc. | — | Food and Beverage | In-kind items and services | $20.25 | General |
| 06/29/2023 | EMD Serono, Inc. | — | Food and Beverage | Cash or cash equivalent | $120.29 | General |
| 06/28/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $22.26 | General |
| Category: Neurology | ||||||
| 06/22/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $123.24 | General |
| Category: Neurology | ||||||
| 05/26/2023 | EMD Serono, Inc. | MAVENCLAD (Drug) | Food and Beverage | Cash or cash equivalent | $95.20 | General |
| Category: Neurology | ||||||
| 05/16/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $23.51 | General |
| Category: Neurology | ||||||
| 05/05/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $17.76 | General |
| Category: Neurology | ||||||
| 03/29/2023 | Biogen, Inc. | TYSABRI (Biological), VUMERITY | Food and Beverage | In-kind items and services | $2.24 | General |
| Category: Neurology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 468 | 520 | $114,255 | $29,905 |
| 2022 | 5 | 249 | 271 | $66,615 | $18,723 |
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 232 | 268 | $58,185 | $15,451 | 26.6% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 33 | 38 | $24,995 | $6,935 | 27.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 68 | 77 | $10,475 | $2,570 | 24.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $9,935 | $2,540 | 25.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 20 | 20 | $6,120 | $1,822 | 29.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 53 | 53 | $3,765 | $458.44 | 12.2% |
| 81002 | Urinalysis, manual test | Office | 2023 | 28 | 30 | $660.00 | $102.30 | 15.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 12 | 12 | $120.00 | $26.40 | 22.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 163 | 181 | $38,515 | $10,595 | 27.5% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2022 | 18 | 19 | $12,470 | $3,837 | 30.8% |
| 99495 | Transitional care management services for problem of moderate complexity | Office | 2022 | 15 | 15 | $7,185 | $2,207 | 30.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 19 | 19 | $5,855 | $1,728 | 29.5% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 34 | 37 | $2,590 | $355.85 | 13.7% |
About Reena Mathew
Reena Mathew is a Emergency healthcare provider based in Norwalk, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2021. The National Provider Identifier (NPI) number assigned to this provider is 1982272084.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Reena Mathew has received a total of $2,300 in payments from pharmaceutical and medical device companies, with $542.60 received in 2024. These payments were reported across 65 transactions from 6 companies. The most common payment nature is "Food and Beverage" ($2,300).
As a Medicare-enrolled provider, Mathew has provided services to 717 Medicare beneficiaries, totaling 791 services with total Medicare billing of $48,628. Data is available for 2 years (2022–2023), covering 13 distinct procedure/service records.
Practice Information
- Specialty Emergency
- Other Specialties Family, Registered Nurse
- Location Norwalk, CT
- Active Since 06/15/2021
- Last Updated 01/04/2022
- Taxonomy Code 163WE0003X
- Entity Type Individual
- NPI Number 1982272084
Products in Payments
- TYSABRI (Biological) $499.58
- MAVENCLAD (Drug) $440.59
- BRIUMVI (Drug) $355.25
- XARELTO (Drug) $160.51
- TAGRISSO (Drug) $119.93
- AVONEX (Biological) $22.26
- VUMERITY (Drug) $20.17
- Ocrevus (Biological) $17.41
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.